These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

528 related items for PubMed ID: 110184

  • 1. U.S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis.
    Long MW, Snider DE, Farer LS.
    Am Rev Respir Dis; 1979 Jun; 119(6):879-94. PubMed ID: 110184
    [Abstract] [Full Text] [Related]

  • 2. Six-months isoniazid-rifampin therapy for pulmonary tuberculosis. Report of a United States Public Health Service Cooperative Trial.
    Snider DE, Long MW, Cross FS, Farer LS.
    Am Rev Respir Dis; 1984 Apr; 129(4):573-9. PubMed ID: 6370060
    [Abstract] [Full Text] [Related]

  • 3. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [Abstract] [Full Text] [Related]

  • 4. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
    Wada M.
    Kekkaku; 2001 Jan; 76(1):33-43. PubMed ID: 11211781
    [Abstract] [Full Text] [Related]

  • 5. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis.
    Grönhagen-Riska C, Hellstrom PE, Fröseth B.
    Am Rev Respir Dis; 1978 Sep; 118(3):461-6. PubMed ID: 707874
    [Abstract] [Full Text] [Related]

  • 6. Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.
    Engbaek HC, Heckscher T, Højgaard C, Larsen SO, Rasmussen KN, Vergmann B.
    Eur J Respir Dis; 1982 Mar; 63(2):84-93. PubMed ID: 7040100
    [Abstract] [Full Text] [Related]

  • 7. [Intermittent chemotherapy from the beginning or only after a period of daily administration? Quantitative bacteriological study at the initial phase of chemotherapy with INH + RMP + EMB in daily or intermittent administration].
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1977 Mar; 26(4):193-205. PubMed ID: 204971
    [Abstract] [Full Text] [Related]

  • 8. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
    Lancet; 1975 Jan 18; 1(7899):119-24. PubMed ID: 46047
    [Abstract] [Full Text] [Related]

  • 9. Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1991 Apr 18; 143(4 Pt 1):707-12. PubMed ID: 1901200
    [Abstract] [Full Text] [Related]

  • 10. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council.
    Am Rev Respir Dis; 1991 Apr 18; 143(4 Pt 1):700-6. PubMed ID: 1901199
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic efficacy of rifampin in newly detected pulmonary tuberculosis.
    Jessamine AG, Gale GL, Eidus L.
    Can Med Assoc J; 1974 May 04; 110(9):1033-7. PubMed ID: 4207234
    [Abstract] [Full Text] [Related]

  • 12. Rifampin in initial treatment of pulmonary tuberculosis. A.U.S. Public Health Service tuberculosis therapy trial.
    Newman R, Doster BE, Murray FJ, Woolpert SF.
    Am Rev Respir Dis; 1974 Feb 04; 109(2):216-32. PubMed ID: 4204541
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of chronic drug-resistant pulmonary tuberculosis with rifampin and ethambutol.
    Jeanes CW, Jessamine AG, Eidus L.
    Can Med Assoc J; 1972 Apr 22; 106(8):884-8. PubMed ID: 4623743
    [Abstract] [Full Text] [Related]

  • 14. The results of 9-month isoniazid-rifampin therapy for pulmonary tuberculosis under program conditions in San Francisco.
    Slutkin G, Schecter GF, Hopewell PC.
    Am Rev Respir Dis; 1988 Dec 22; 138(6):1622-4. PubMed ID: 3144221
    [Abstract] [Full Text] [Related]

  • 15. Smear-negative, culture-positive pulmonary tuberculosis. Six-month chemotherapy with isoniazid and rifampin.
    Dutt AK, Moers D, Stead WW.
    Am Rev Respir Dis; 1990 May 22; 141(5 Pt 1):1232-5. PubMed ID: 2111106
    [Abstract] [Full Text] [Related]

  • 16. Short-course chemotherapy for tuberculosis with mainly twice-weekly isoniazid and rifampin. Community physicians' seven-year experience with mainly outpatients.
    Dutt AK, Moers D, Stead WW.
    Am J Med; 1984 Aug 22; 77(2):233-42. PubMed ID: 6431810
    [Abstract] [Full Text] [Related]

  • 17. Rifampin in initial treatment of pulmonary tuberculosis. A U.S. Public Health Service tuberculosis therapy trial.
    Newman R, Doster B, Murray FJ, Ferebee S.
    Am Rev Respir Dis; 1971 Apr 22; 103(4):461-76. PubMed ID: 4994459
    [No Abstract] [Full Text] [Related]

  • 18. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec 22; 1(6):509-17. PubMed ID: 9487448
    [Abstract] [Full Text] [Related]

  • 19. Short-course (6 month) cooperative tuberculosis study in Poland: results 18 months after completion of treatment.
    Zierski M, Bek E, Long MW, Snider DE.
    Am Rev Respir Dis; 1980 Dec 22; 122(6):879-89. PubMed ID: 7006476
    [Abstract] [Full Text] [Related]

  • 20. [Assessment of the use of a multicomponent drug in the treatment of new cases of pulmonary tuberculosis].
    Semenova OV.
    Probl Tuberk Bolezn Legk; 2003 Dec 22; (11):22-5. PubMed ID: 14689793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.